Welcome to UK420

Register now to gain access to all of our features. Once registered and logged in, you will be able to contribute to this site by submitting your own content or replying to existing content. You'll be able to customize your profile, receive reputation points as a reward for submitting content, while also communicating with other members via your own private inbox, plus much more!

This message will be removed once you have signed in.

Search the Community: Showing results for tags 'uk'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Welcome to UK420
    • New Members
  • Cultivation
    • Strain Base
    • Breeders Help Desks
    • Compost and Pots
    • Hydroponics
    • Outdoor Growing
    • Propagation, Cloning and Mother Plants
    • Auto Flowering
    • Growroom Design
    • Problem Solver
    • Harvesting and Processing
    • Grow Diaries
    • Cream Of The Crop
  • Cannabis Culture
    • News, Views and Politics
    • Medicinal Cannabis
    • Smokers Lounge
    • Uk420 Competitions
  • Sponsor Support
    • Intense Nutrients
    • Vapefiend - The Vaporizer Specialists
    • DIY LED UK
    • Gro-zone Hydro


  • Community Calendar

Found 5,424 results

  1. Hi Rival candidates predict legalised cannabis on way for UK It is only a matter of time until cannabis is legalised in the UK, candidates for both Labour and the Conservatives have predicted. Despite being on opposite sides of the General Election campaign, the issue was something David Lammy and Crispin Blunt agreed on during a panel at the Global Cannabis Institute's Leaders' Summit. They were joined by former Lib Dem MP and ex chairman of the Commons Science and Technology Committee Sir Norman Lamb, and Baroness Molly Meacher. Cannabis is currently designated as a Class B drug in the UK and its recreational use is illegal. However, there has been a shift in attitude towards medicinal products, with the first cannabis-based medicines approved for use on the NHS on Monday. Such moves in other countries has often lead to a relaxation in rules around recreational cannabis taking. Speaking at the summit in London, Labour parliamentary candidate Mr Lammy said: "I think my own judgment is that generationally Parliament is also moving and changing. "I think that we are arriving at a position where I don't think we are now any longer in the place where 'will there be regulation and legalisation?', I think it is more about how and when. "And I suspect on how, there are differences in approaches that the two main parties will take, but I think that this is probably going to happen in the next decade or so." Tory candidate Mr Blunt said the UK's current cannabis policy had made it very difficult to conduct research on how it can be used in medicine. He added: "What I am arguing to my colleagues is what we need is policy based on evidence - I am not arguing for an outcome. "I am arguing to try and create the right environment to consider the evidence. "It looks as though it is more likely than not to happen." Mr Blunt told the conference he was not sure how long it would take for such regulations to be created. Sir Norman had previously led his party's decision to back the legalisation of cannabis. He became possibly the first serving British MP to openly take a cannabis product on camera after sampling a version of the oil containing THC for a documentary filmed in Canada. THC is a compound within cannabis which gets users high and it is removed from CBD oil products that can currently be brought in UK shops. Explaining why he backed the legalisation, Sir Norman said: "My argument has been two-fold: first of all as a liberal, what on earth has the state got to do with what people choose to do in terms of an activity that does not impact on other people? "This should be the basis for law-making, it seems to me. "Particularly the hypocrisy when in our Parliament vast volumes of another drug of choice is consumed in the bars around Westminster, a drug that is much more dangerous of course than cannabis," Sir Norman claimed. "But also my argument has been on the public health basis, because I think we put particularly young people at risk because of the stupid approach that we take through prohibition." https://www.chronicle.gi/rival-candidates-predict-legalised-cannabis-on-way-for-uk/ Bongme
  2. hi Canterbury cannabis farm found during police raid in Ruttington Lane More than 200 cannabis plants have been found at a city centre home. Officers raided an address in Ruttington Lane, Canterbury, and discovered the huge cultivation operation. Two rooms were being used to dry a large quantity of cannabis bud, with a further 224 plants in the early stages of growth. They were removed from the property following the raid last Monday. No arrests have been made and officers are keen to hear from anyone who has witnessed suspicious activity in the area. https://www.kentonline.co.uk/canterbury/news/224-cannabis-plants-found-in-city-centre-home-216164/ Bongme
  3. hi Cruel dog owner masked pet's pain with CANNABIS instead of taking her to vets Nathan Sinnitt's Mastiff bitch had to be put to sleep after the effects of the drug wore off and she was in agony A dog owner has avoided jail after he masked his pet's extreme pain with second hand cannabis smoke inhalation instead of taking her to the vets. Misty, a Mastiff-type animal, was seized after police raided the home of Nathan Sinnitt in relation to a suspected drugs farm. A court heard that officers found the pet calm but unable to stand or walk properly. When questioned, Sinnitt and his partner admitted Misty hadn't been walked or left the house in over eight months because of her mobility issues. RSPCA officers were called and the dog was taken to a vets but, less than 12 hours later, she was in such extreme pain that she had to be put to sleep, prosecutors said. The vet confirmed that Misty had first appeared calm because of the effects of cannabis inhalation but those effects soon wore off, the court heard. Sinnett, of Victoria Avenue, Wallsend, was due before magistrates in North Tyneside last week but failed to show. He was found guilty in absence of causing unnecessary to an animal and a warrant was issued for his arrest. But the 30-year-old handed himself in to police on Tuesday and he appeared in the dock to be sentenced the same day. Stewart Haywood, prosecuting, told magistrates that police raided Sinnitt's home on August 12 this year before calling in the RSPCA on discovering Misty. "Inspectors attended and saw Misty," he said. "Misty was sitting and, at the time she went to get up, she was very unsteady and struggling to put weight on her front legs and her back legs were unco-ordinated. She fell a number of times when trying to get up." Misty was taken to the vet, who noted she was also struggling with pressure sores and that her skin showed areas of excessive licking. Mr Haywood added: "The following day, Misty was seen and had clearly deteriorated. She was in pain. "It's the opinion of the vet that, being in the presence of cannabis would have masked the level of Misty's pain after inhalation, which is why she didn't feel the extent of the pain until the following day." The vet determined that there had been "significant, prolonged suffering" for Misty over a number of months. And her condition was so bad, it was deemed that the most humane action was to put the pet to sleep, Mr Haywood told magistrates. It was also revealed that Sinnitt was entitled to PDSA treatment and lived just 200 yards from a vet. Mr Haywood said: "It appears in this case that the defendant couldn't be bothered to walk the short distance to take Misty to a vet and, instead, decided to take on a criminal lifestyle and grow and smoke cannabis." The court heard Sinnitt's partner also failed to attend a court hearing last week and the case was also proved in absence against her. A warrant was also issued for her arrest and is still outstanding. Mark Harrison, defending, said Sinnitt hadn't deliberately been cruel to Misty but had failed to get her the necessary medical treament. He told the court: "These are always emotive cases. The defendant has not been prosecuted for any cannabis recovered from his home address. "I also don't consider it to be a particularly helpful point that he should be given any credit for lowering or suppressing Misty's harm by cannabis. "I don't mitigate on the basis Misty's harm was lowered because of her inhalation of second hand cannabis smoke. In fact, I'm not even sure of the science to argue it anyway." Mr Harrison said Sinnitt was thoroughly ashamed, embarrassed and upset as the dog was initially bought for him to help with his mental health. Sinnitt was given a 12-week prison sentence, suspended for 18 months, and was banned from keeping animals for five years. https://www.chroniclelive.co.uk/news/north-east-news/cruel-dog-owner-masked-pets-17250052 Bongme
  4. hi Only Big Business has real weed now what we have is the new name for you 'Street Skunk' no matter what strain you grow! ----0 This Is What You Can – And Can't – Take Medical Cannabis For A year after cannabis-based medicinal products were legalised for prescription in England, Wales and Scotland, new guidelines have been issued about how – and for what – they should be prescribed. The move to legalise medicinal cannabis followed several high-profile cases, including those of young epilepsy sufferers Alfie Dingley and Billy Caldwell, whose conditions appeared to be helped by cannabis oil. Calls for legalisation also came from people with multiple sclerosis (MS) and chronic pain – and their campaigning did not stop with a change in the law. Just 12 NHS prescriptions for medicinal cannabis had been issued by the end of September 2019, The Telegraph reported. In early November, doctors and people living with multiple sclerosis (MS) revealed “systemic issues” with the prescribing of cannabis-based products for the condition. Rhona, 52, who was diagnosed with MS in 1994, was one of them. “Whenever I’ve asked any of my medical team about getting cannabis on prescription, they don’t how they can prescribe it,” she told the MS Society. “When I know there is something that could make me more productive, it feels very unfair.” Families In Need Of Cannabis Oil Say Doctors Still Associate It With ‘Street Skunk’ There is limited evidence of the effects of medicinal cannabis, and very little long-term research, which means experts are reluctant to prescribe it en masse until more clinical trials have taken place. Licensing is also an issue – very few products are actually licensed for medicinal use in the UK and there is no dedicated medicinal cannabis regulatory system, unlike other countries. But hope is on the horizon for campaigners. At the start of November, it was announced that up to 20,000 patients in the UK are to be given medical cannabis over a two-year period to build up a larger body of evidence. Dependent on its findings, this major trial could lead to medicinal cannabis becoming more widely available and affordable to those who need it. In the meantime, the new guidelines from the National Institute For Health And Care Excellence (NICE) will inform NHS strategies and provide some clarity. Who can prescribe medicinal cannabis? The medicines can only be prescribed by a specialist doctor – not a GP – on a case-by-case basis. The only legal alternative to medicinal cannabis on the NHS is a private prescription, which can cost anywhere up to £4,000 a month. Others have taken illegal routes, including bringing medicinal cannabis into the UK from abroad and growing their own cannabis plants, asking the police for amnesty. Since legalisation, even specialist doctors have struggled to gain access. Dr Eli Silber, a consultant neurologist at Kings College Hospital NHS Foundation Trust, said that she hadn’t been able to help a single one of her MS patients obtain a prescription. “The current limitations on prescribing and funding actively discourage clinicians from prescribing cannabis, leaving no flexibility for us to act in the best interest of our patients,” said Dr Silber. What can medicinal cannabis be prescribed for? Two cannabis-based medicinal products have been recommended for use for the first time under the NICE guidance – although NHS England does advise that medicinal cannabis should be used only after other treatment options have been exhausted. Epidyolex, which contains highly purified cannabidiol (CBD), has been approved to treat two rare types of epilepsy: Lennox-Gastaut and Dravet syndromes. Sativex, a THC:CBD spray, has been recommended to treat severe muscle spasms in people with multiple sclerosis (MS). The mouth spray contains two chemical extracts derived from the cannabis plant: delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). People looking to obtain Sativex had previously encountered issues. Noeline, 64, from Cumbria, has lived with MS since 2013 and said she asked her doctor about obtaining the spray after medicinal cannabis was legalised: “He said he couldn’t prescribe it for a good few years yet because of all the red tape.” As part of the NICE guidance, doctors treatment adults with chemotherapy-induced nausea and vomiting, can also now consider prescribing nabilone, a synthetic cannabinoid, as an add-on treatment. What can’t medicinal cannabis be prescribed for? Under the new guidelines, people with chronic pain will no longer be prescribed cannabis-based products such as nabilone, dronabinol, THC (delta-9-tetrahydrocannabinol), and a combination of cannabidiol (CBD) with THC. They may be prescribed cannabidiol (a pure, plant-derived cannabinoid) on its own but only in the context of a clinical trial. “Adults who started cannabis-based medicinal products to manage chronic pain in the NHS before this guidance was published should be able to continue treatment until they and their NHS clinician think it appropriate to stop,” the NICE guidance advises. A spokesperson told HuffPost UK this is because these products offer patients are very small compared with their high costs, so they cannot be considered a cost-effective use of NHS resources. The news will come as a disappointment for those with chronic pain, people like Carly Barton, who says patients are being let down. “Cannabis has already been through the biggest ‘trial’ known to man, it is out there and it is working, we should be looking at how to collect that data,” she wrote in an opinion piece for HuffPost UK. “It is an insult to patients to suggest that their experiences with their own bodies are not valid when making decisions about their treatment.” What about CBD oil on the high street? The Royal College Of Paediatrics and Child Health (RCPCH) advises parents not to give children with epilepsy CBD oil products bought online or over the counter, as there’s currently no evidence that these products make for effective treatment. There’s also a risk they will interfere with prescribed medications. These products are not classed as medicines, are unlicensed, and tend to have varying levels of ingredients, so it’s impossible to know what is in the products but also what impact (if any) they may be having on health. Furthermore, some such products contain very high levels of THC and these pose “significant theoretical risks” to children. The new NICE guidelines don’t make any recommendations about the use of unlicensed cannabis-based medicines for severe treatment-resistant epilepsy. Do the new guidelines go far enough? Ley Sander, medical director at the Epilepsy Society and professor of neurology at University College London (UCL), said the NICE guidelines “will bring hope” to many families affected by Lennox-Gastaut and Dravet syndromes. “The need for new treatment options is unquestionable and it is reassuring that the new medication has been through clinical trials and regulatory processes.” The timeframe of research and testing means doctors “still cannot be certain of the long-term efficacy of this CBD product or what its effect might be on the developing brain”, said Professor Sander, who warned that medicinal cannabis is “not a magic bullet” and, like other anti-seizure medications, is likely to work for some but not for others. Mark Devlin, chief executive of Young Epilepsy, said it was unclear if the NICE guidelines would have an immediate impact on prescriptions for children and young people with epilepsy, beyond those who meet the strict criteria for CBD. “Many families have received mixed messages about whether their child might have access to cannabis-based medicines. It’s vital that families get the best information to help them make decisions with their specialists about the appropriate treatment options available to their children,” said Devlin. Global cannabis expert Marc Davis, who advises some of the world’s largest suppliers of medicinal cannabis, told HuffPost UK that while the approval of Epidyolex and Sativex spray “is a crucial step in the right direction”, ultimately the guidelines do not go far enough and leave countless patients “at a loss”. He called the guidelines a “huge missed opportunity” for the UK, where a medicinal cannabis regulatory system is “urgently” needed. “Further clinical research, physician education and continued patient advocacy should help to challenge misinformed perceptions, prejudices and medical apprehension that is fuelling an anti-cannabis hysteria,” he added. https://www.huffingtonpost.co.uk/entry/medicinal-cannabis-guidelines_uk_5dc92d0de4b0fcfb7f696669?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAANB7SNC8a42SxB7we2K01MJfT2GKscL6LpQ-Rf-h_yb6rOohhDfkQ2JXqBH1q89IRuCNrYDSO2krSBU_V9vA3nPG_I7ZCqeXQpX1J0RpMSmfzZUmZS4L9XVtSlqwtztnTMgD0Sgg2pi1Kt2QA4uPPK4FntREitpkDQvyaGi_nStN Bongme
  5. hi Man charged after raid uncovered cannabis farm in Wallasey Detectives investigating a cannabis farm found in Wallasey earlier this week have charged a man with cannabis production. At 10.30am on Monday, November 11, officers carried out a search warrant at an address on Mount Pleasant Road and detained a man. A cannabis crop was located of approximately 60 plants. Further forensic inquiries were carried out at the premises. Altay Teyarecioglu, 52, from Mount Pleasant Road, has now been charged with production of cannabis and appeared at Wirral Adult Remand Court on Tuesday, November 12. Teyarecioglu has been remanded in custody to appear at Liverpool Crown Court for trial on Tuesday, December 10. https://www.wirralglobe.co.uk/news/18033582.man-charged-raid-uncovered-cannabis-farm-wallasey/ Bongme
  6. hi Cheshire man admits to buying cannabis for terminally ill brother Exclusive: Ben Findlay, who bought drugs for £5k to make painkilling oil, has come clean to highlight cruelty of law Guardian A Cheshire businessman has admitted to buying cannabis and turning it into what he claims was a painkilling oil to help his terminally ill brother, in an attempt to highlight “the stupidity and cruelty” of drug prohibition. Ben Findlay has told the Guardian he spent up to £5,000 obtaining the drug from criminals earlier this year. He then turned his garage into a makeshift laboratory to convert the cannabis into a medicinal mix that his brother Eric, who had cancer, ingested in the weeks before his death. Findlay, a 36-year-old entrepreneur, said he was willing to face prosecution over buying and “cooking” the cannabis as an alternative to morphine. Speaking at his home on the Cheshire/North Wales border, he said his brother Eric, who was 14 months older than him, was a supremely fit, highly driven character. “He was diagnosed with cancer which had spread in April, shortly after Easter, which was a terrible shock to us all given that he had a very healthy lifestyle. What is cannabis oil and how does it work? Read more “People used to call us Danny DeVito and Arnold Schwarzenegger from the film Twins. Given how fit Eric was, I was obviously Danny DeVito,” he said. Ben Findlay said his brother decided after being told he was terminally ill that he wanted to be lucid throughout his end of life care. “Very quickly after diagnosis, Eric was in a lot of pain as the tumours spread and the medical team offered him codeine, and eventually morphine. At first, we thought there was some hope through alternative immunology therapy that might have saved him. So that meant he had to stay off morphine because he would have been too weak from it to go on that programme. “Eventually, when it was clear he was going to die, Eric told us he wanted to be calm, clear, lucid and in charge of his affairs. I had been looking into medical cannabis as a possible alternative to the morphine because he feared that that would knock him out most of the time. I was determined to meet his wishes. I managed to contact a pharmacist who guided me as to how to convert the cannabis into a liquid form that Eric could ingest. All the time, Eric stressed that this was what he wanted; this was how he wanted to be treated for the pain.” Transforming his garage into a makeshift lab, Ben Findlay said he was able to process the cannabis into a sludge. “I put the sludge into those syringes that you give kids medicine like Calpol with and Eric was able to squeeze them out and swallow them when the pain really kicked in. Right up until the last day of his life I said that it was an effective pain relief. Most importantly he stayed lucid to the end and was able to make decisions about his family’s future, and crucially say goodbye properly to his wife Mo and his two children. He told his wife that he loved her very much and that his children were beautiful. “He might have been high and calm with the medical cannabis I made up for him but Eric was there with us, he knew what he was saying, he was able to say those very important things at the end,” Ben Findlay said. Asked about his admission over buying and processing the cannabis, he added: “I know I was risking my liberty, my business, my family but I have no regrets giving Eric a relatively pain-free, lucid last few weeks with those that loved him all around. “If I was arrested now I would not accept a caution; I would prefer to be tried by my peers in court. The law becomes redundant when it stops protecting people. Prohibition did not protect my brother. Eric wanted medicinal cannabis for his final few weeks on earth and it was my duty to get him it. I have absolutely no regrets.” https://www.theguardian.com/society/2019/nov/13/cheshire-man-admits-to-buying-cannabis-for-terminally-ill-brother Bongme
  7. hi Remarkable transformation of seriously ill boy after he’s treated with cannabis oil The picture on the left shows a boy, with severe epilepsy, on a normal day two years ago. Having been pumped with pharmaceutical drugs since he was a baby, he suffered countless seizures, could only see lights, and was in a ‘vegetative state’. The picture on the right shows that same boy today, while being treated with cannabis-derived CBD and THC oil, with practically no medication. Now, eight-year-old Eddie Woodman ‘has the sparkle back in his eyes’ and his seizures have reduced dramatically. He giggles, loves swimming and squeals with delight when he’s pushed on a swing, when before he would barely flinch. Mum Geraldine Woodman, 43, told Metro.co.uk how she has fought off social workers and gone against doctor’s advice to ‘do what is right’ for her son and said the stigma against cannabis is ‘ridiculous’. Her comments come after it was announced earlier this week that two cannabis-based medicines had been approved on the NHS to treat certain types of epilepsy and multiple sclerosis. Updated guidelines by Nice, the UK drugs advisory body, will now permit doctors to administer Epidyolex to children with two types of epilepsy. The drug contains CBD but not THC – the psychoactive element of the plant. Sativex, a mouth spray containing both components, will be prescribed for muscle stiffness and spasms for patients with multiple sclerosis – but not for the severe pain that comes with the condition. Although many have praised the move, some campaigners argue the new guidelines are not good enough, as many families will still be forced to pay thousands per year to fund treatments containing both CBD and THC elements. In November 2018, the law was changed to allow specialist doctors to prescribe cannabis medicines but many have been reluctant to do so citing a lack of research. End Our Pain, a campaign group fighting for the legalisation of medical cannabis for all, described the new guidelines as a ‘massive missed opportunity’. Spokeswoman, Millie Hinton, said: ‘This restrictive guidance is condemning many patients to having to pay for life-transforming medicine privately, to go without or to consider accessing illegal and unregulated sources.’ Geraldine was one of those parents who did not welcome the move, as the drugs will not treat her son who has intractable epilepsy, meaning his seizures cannot be controlled with medication. She said Eddie’s symptoms only reduce when he is given CBD oil containing the THC element – which has not been approved by Nice – and said the new guidelines are depriving thousands of Britons of a better quality of life. Geraldine, from Driffield, East Yorkshire, said: ‘Why are we segregating people over a plant that works for a lot more types of epilepsy? And what about people with cancer? ‘It shouldn’t be about just two types of epilepsy, or a certain condition, or a certain group, or a certain age – it should be about everyone. ‘It is wrong what the government has done.’ Eddie was born 11 weeks premature and suffered a bleed on the brain but despite this he seemed to be developing normally. A few months later, the stay-at-home mother noticed her son was crying a lot and ‘knew something wasn’t right’ but doctors dismissed it as acid reflux and prescribed Gaviscon. At nine months, Eddie suffered a ‘huge seizure’ and was rushed to hospital, where medics diagnosed him with infantile spasms – an aggressive form of epilepsy. Eddie was left severely brain damaged and unable to walk, talk, or eat unassisted. ‘Ever since that day, they kept giving him medication to knock him out because every time he’d open his eyes he’d have a seizure,’ said Geraldine. ‘Within 20 seconds of him waking up you would see him have a cluster of seizures for around an hour.’ By the age of six, Eddie was taking 60mg of drugs a day, causing him to be ‘absolutely zonked’ and mostly stared into space. But the more medication that was introduced, came more side effects, so more drugs were prescribed to reduce them. Geraldine was told one medication could ‘wreak havoc with his eyesight’ – he eventually lost peripheral vision and was only able to see light. In early 2018, his seizures worsened. Eddie lost all enthusiasm for life and ‘would scream blue murder at school’. When doctors suggested upping the young boy’s medication further, Geraldine had had enough and started to look for alternative therapies. And within a few months of taking US-imported CBD-THC oil, Eddie began to see from a distance and even track people around the room, but most of all, his seizures reduced dramatically. ‘We can see it when we look in his eyes, they have that sparkle back. Now he makes a lot of noise, he’s a big talker, he’s calm in class, he does swimming and music,’ said Geraldine. Bit by bit, his pharmaceutical medication was reduced and he has since dropped down to just 1mg, with doctors’ letters confirming the young boy’s dramatic improvement. ‘He takes a CBD-THC ratio but it is a small amount of THC, so it’s not enough to get him stoned,’ said Geraldine. ‘It’s not damaging him, he has no side effects at all. ‘It’s not a cure but it is giving him an alternative so he can have some quality of life instead of being on a pharmaceutical rollercoaster where he can’t function.’ But the mother-of-seven has faced many obstacles in her pursuit to help her son, after someone tipped off social services about her alternative methods. After watching her for some months, the social worker no longer pays her visits and Geraldine thinks it’s down to ‘Steady Eddie’s’ new-found joy for life. Geraldine continued: ‘There have been so many times I’ve felt like giving up. Then I look at him and think, what other chances have I got? ‘I can’t put him back in that vegetative state and sat there all high.’ Through tears, the mother explained how she trusted her instinct to prove others wrong and questioned what mother wouldn’t do the same for their child. For now, the mother won’t give up her fight to treat Eddie her way and said the government should allow doctors to prescribe CBD oil and give adults the opportunity to self-medicate with cannabis. Geraldine added: ‘If it works for someone, let them choose.’ https://metro.co.uk/2019/11/13/remarkable-transformation-seriously-boy-treated-cannabis-oil-11086471/ More Photos Bongme
  8. Hi Cirque du Soleil founder detained for growing cannabis on private island BBC News The co-founder of global circus company Cirque du Soleil has been detained for growing cannabis on his private island in the South Pacific. Billionaire Guy Laliberte turned himself in to police in French Polynesia. The Canadian entrepreneur is due to appear in court on Wednesday. In a statement, Mr Laliberte's company Lune Rouge denied he was growing the plant on his private island of Nukutepipi for commercial gain. It said that he used cannabis for "medical" and "strictly personal" purposes. "Guy Laliberte completely dissociates himself from any rumour implicating him... in the sale or traffic of drugs," it said. Local television station Polynesie Premiere reported that police questioned an associate of Mr Laliberte weeks ago on suspicion of drug possession. They reportedly found images of marijuana plantations on the associate's cell phone. In 2015, Cirque du Soleil was sold to US and Chinese investors, but Mr Laliberte retains a minority stake in the company. https://www.bbc.co.uk/news/world-asia-50403268 Bongme
  9. Hi Calls grow for better support and care for individuals considering medicinal cannabis for treatment A new advocacy group chaired by the former health minister, Ann Keen RN, has called for better patient access and care to regulated medicinal cannabis. Cannabis Patient Advocacy and Support Services (CPASS) is working with charity groups and healthcare providers to aid those with long term conditions such as resistant epilepsy, MS and chemotherapy-induced nausea and vomiting. Keen said at the event: “As a former community District Nursing Sister, I am aware that today’s Nurses require education and training to inform and support the patient and family with the best knowledge that we have, with the most up to date understanding of cannabis-based medicinal products.” CPASS launched on November 12 at the Royal College of Nursing with advocates calling for clinical nurse specialist (CNS nurses) to deliver the best care for patients in light of upcoming announcements regarding cannabis-based medicinal products. Advisory board member to CPASS, Dr Lina Eliasson, PhD, said: “I salute the Royal College of Nursing for taking the lead amongst professional healthcare bodies to support medical cannabis reform in the UK. “I hope other medical Royal Colleges and Faculties follow suit to ensure that all healthcare professionals are appropriately informed. This would reduce the stigma still attached to using cannabis-based medical products as well as facilitate the implementation of safe and effective processes for prescription and supply of medical cannabis to those in need”. https://www.homecareinsight.co.uk/calls-grow-for-better-support-and-care-for-individuals-considering-cannabis-for-medicinal-treatment/ Bongme
  10. hi Scotland cannot fall behind on cannabis-based medicines – Steve Cardownie Parents’ accounts of how children who suffer severe epileptic seizures benefit from cannabis oil treatment must be taken seriously, writes Steve Cardownie. Back in April last year I reported in my ­column under the heading “Cannabis-based drugs may soon be on NHS” that it would surely only be a matter of time before cannabidiol (CBD) would be made available. Now the recent announcement that the NHS in ­England has approved two cannabis-based medicines for use in the treatment of epilepsy and multiple sclerosis has brought it a step closer. New guidelines have been issued from Nice, the drugs advisory body, which has led to doctors being allowed to prescribe Epidyolex for children with two types of severe epilepsy which can cause multiple seizures a day. Clinical trials have demonstrated that an oral solution containing CBD (which does not contain THC, the main psychoactive component of cannabis) could reduce the number of seizures by up to 40 per cent in some children. The other treatment, Sativex, a mouth spray that contains a mix of THC and CBD, has been approved for treating muscle stiffness and spasms experienced by people with multiple sclerosis. It has been available on the NHS in Wales since 2014 – but at a cost of £2,000 per year for the treatment it was deemed “not cost effective” by regulators in England, although this new announcement reverses that decision. Hopefully the NHS in Scotland will follow suit next year, but does this welcome move go far enough? Parents become smugglers Doctors will be prohibited from prescribing the drug to alleviate pain which is a common symptom of MS. This has caused the MS Society to criticise the guidelines as not going far enough, with campaigners pledging to continue their fight to get the approval extended to cover other symptoms. Parents and guardians of children who have epilepsy have spoken about marked reductions in the number and severity of seizures suffered by their children when given medicines imported from the Continent and Canada which contain both CBD and, crucially, THC. Paying up to thousands of pounds a month for these medicines, they are angry that the drugs approved for the treatment of epilepsy only contain CBD, not both components which they say their children need. It is not a ‘one-size-fits-all’ solution and they want their demands met. One oil that has so far been effective in reducing seizures for some children contains nine per cent CBD and less than one per cent THC but it is produced in the Netherlands. It is illegal to bring it into the UK without the appropriate import licence, leading some parents to bring the oil in illegally. Reforms gathering pace Billy Caldwell, a boy from Northern Ireland who suffered up to 100 seizures a day, has had none in almost a year after being treated with cannabis oil which, according to his mother, has also improved his autism, with better eye contact and interaction with toys and books. Perhaps tellingly, he also takes a supplement containing THC which, as I explained above, has not been sanctioned for the treatment of epilepsy. So reforms appear to be gathering pace, but not as quickly as some would like. The testimony from parents that some children suffering epileptic seizures do benefit from cannabis oil treatment has been recognised by health practitioners throughout the UK (although it is fair to say that some do have reservations as to its effectiveness and long-term potential consequences) and action, however slowly, has been taken. The NHS in Scotland cannot fail to have taken the new developments in the health sector into account and is likely to soon follow suit. But why not go further and replicate the policies adopted by some countries beyond these shores and issue guidelines that would allow cannabis oil which contains both CBD and THC to be prescribed on the NHS? This might go a long way in alleviating the suffering of children and the anguish of parents who have to witness their child having multiple seizures on a daily basis. https://www.edinburghnews.scotsman.com/health/scotland-cannot-fall-behind-cannabis-based-medicines-steve-cardownie-975954 Bongme
  11. hi Six men and boy accused of running £1m cannabis factory due in court Six men and a boy will appear at court this morning charged with running a £1m cannabis factory on a Norfolk industrial estate. Officers seized more than 1,000 cannabis plants as they disassembled an "extremely professional" set-up inside a two-storey building in Lenwade, between Norwich and Fakenham in July. Five men have since denied producing a quantity of cannabis, a controlled drug of class B. They are; - Vedot Koc, 42, from London; - Leonardo Motera, 18, from London; - Mevlan Cena, 22, of no fixed address; - Potja Shprim, 31, of no fixed address; - Viktor Mihayov, 23, from London; - Kien Le, 26, of no fixed address - A 15-year-old boy who cannot be named for legal reasons They will appear at Norwich Crown Court for a pre-trial review this morning. https://www.edp24.co.uk/news/crime/men-accused-of-1m-norfolk-cannabis-factory-1-6372523 Bongme
  12. hi Poll Results: Use Of Street Cannabis Medicinally In The UK Hempgazette A new poll reveals 2.8% of the British adult population is using “street cannabis” for medicinal purposes – up to 1.4 million people. A survey carried out for the Center for Medicinal Cannabis (CMC) and Cannabis Patient Advocacy & Support Services (CPASS) by YouGov found the number of people using illicit cannabis medicinally appears to be far higher than previous reports that pegged the numbers anywhere from 50,000 and 1.1 million. “The findings are astounding and present a national challenge,” said CMC’s Medical Lead, Dr Daniel Couch. “We urgently require robust clinical evidence to evaluate the safety and efficacy of cannabinoid medicines.” Of the group using street cannabis medicinally, the polling found: 56% were using cannabis on a daily basis to manage their condition. 23% are using cannabis a weekly basis. 9% spent nothing on cannabis – this indicates self-growing (or perhaps gifted) 44% spent up to £99 per month. 21% are spending between £100 and £199 Initial results from the poll were released on the same day National Institute for Health and Care Excellence (NICE) guidelines were released for prescribing cannabis-based medicinal products for patients with intractable nausea and vomiting, chronic pain, MS related spasticity and severe treatment-resistant epilepsy. Two products have been approved for use under the National Health Service (NHS) – Epidyolex and Sativex. Epidyolex (known as Epidiolex outside the EU) is a very expensive cannabidiol (CBD) based product. Maker GW Pharmaceuticals announced in September it had received marketing authorisation for the formulation in all 28 EU countries plus Norway, Iceland and Liechtenstein. Epidyolex is primarily used for managing seizures in severe forms of childhood epilepsy. It was approved for use in managing Lennox‑Gastaut syndrome (LGS) and Dravet syndrome by the US FDA in June last year. Sativex is a tetrahydrocannabinol-cannabidiol (THC : CBD) oromucosal spray primarily used for treating muscle spasticity in multiple sclerosis (MS) patients. The CMC welcomed the new NICE guidelines but urged the Government to accelerate patient access and clinical learning via the NHS based on the results of the polling data. The body said it will soon set out new proposals for how NICE should evaluate cannabis based medicinal products over the next 5-10 years. The CMC welcomed the new NICE guidelines but urged the Government to accelerate patient access and clinical learning via the NHS based on the results of the polling data. The body said it will soon set out new proposals for how NICE should evaluate cannabis based medicinal products over the next 5-10 years. https://hempgazette.com/news/cannabis-uk-hg1043/ Bongme
  13. Hi UK Cannabis Market on the Brink of Change Those attempting to track the meandering Brexit trail in the three years since the referendum which decided that the United Kingdom (UK) would leave the European Union (EU) are well aware that the general election on 12 December most likely will determine the path forward. What that might mean for the cannabis market in the UK is less discussed. Election front-runners, the Conservatives and Labour Parties, which recent polls projected to have 41 and 29 percent of the votes respectively, both have been reticent to support the use of cannabis-based products. The Liberal Democrats, with less than 15 percent of the projected votes, and the Greens with even less, both support liberalization. As recently as this summer, however, a cross-party group of Members of the UK Parliament returned from a study visit in Canada prepared to vote against party lines. As the UK potentially moves toward under a revitalized Conservative government to seal a deal with the EU before 31 January 2020 predicate to embarking on a process of resetting its rules as an independent nation, there is plenty of opportunity for change. The UK re-branding undoubtedly will seek to build on its reputation for excellence in research and development in the life sciences sector, including its extensive expertise in clinical studies of potential new treatments. The future may well include a significant increase in clinical research on cannabis products. On 11 November 2019, the UK’s National Institute for Health and Care Excellence (NICE) published guidance that clears the way for two cannabis-based medicines to be used within the UK’s National Health System (NHS). NICE reversed the position it took in draft guidance in August when it questioned the efficacy GW Pharma’s Epidiolex despite the European Medicines Agency approving it in September for the entire EU market. NICE also overcame its hesitancy concerning the pricing of Epidiolex as well as Sativex, another GW Pharma product, approved for medicinal use in the UK in 2010 but which NICE had rejected earlier this year as not cost-effective. Subsequent work between NICE and GW Pharma on economic modelling as well as public consultations paved the way for the change in position. Medical cannabis was legalised in the UK in November 2018 under certain conditions. NICE’s guidance enables, for the first time, NHS specialists to prescribe cannabis-based products for patients across England. Epidiolex, a purified cannabidiol (CBD) solution, is used to treat seizures in children with Lennos Gastaut or Dravat syndromes while Sativex, which contains equal portions CBD and tetrahydocannabinol (THC), treats spasticity related to multiple sclerosis. Sativex will be available only when other treatments have failed and where local NHS authorities agree to cover costs for a four week period. Continuation of the treatment by prescription from a general practitioner is possible where symptoms improve by at least twenty percent during the trial period. NICE’s recommendation on Sativex was welcomed by the MS (multiple sclerosis) Trust. Similarly, Epilepsy Action considers the recommendation on Epidiolex to be an important step forward but calls for more research on the use of medicines containing THC for epilepsy patients. The patient advocacy group End our Pain, which last spring brought families of patients with epilepsy to the offices of more than 80 Members of the UK Parliament, has criticized the NICE guidance for not also recommending medicines with THC for NHS use in treating symptoms of epilepsy. Whomever ends up in office to guide the UK through the coming rocky steps can expect to hear plenty more from constituents about the potential benefits of cannabis-based products and the need for regulatory reform. https://www.jdsupra.com/legalnews/uk-cannabis-market-on-the-brink-of-81226/ Bongme
  14. hi Teen fined after being caught with cannabis worth £100 A teenager has been fined after being caught with £100 of cannabis in a village. Henry Calton, 19, of Old Hall Farm in Burston, appeared at Norwich Magistrates' Court on November 12 where he pleaded guilty to possession of cannabis and herbal cannabis. Prosecuting, Robyn Khan said the teenager was found with the drugs in his Volkswagen Golf on Bridge Road, Scole, near Diss, on July 10. Giving evidence, Miss Khan said the teenager was in the car with three other friends at the time and had just picked up cannabis with a street value of £100. He also had a small amount of herbal cannabis and a cannabis grinder, all of which will be destroyed. The police officer was alerted to Calton's car because of a strong smell of cannabis. Mitigating, Ryan Creek said: "He had gone out with friends for the evening and purchased cannabis. The cannabis was for his own personal use. I don't think he could have co-operated more fully." Mr Creek said Calton, who works full time on his father's farm, had a good home life but did have depression, which is why he sometimes used cannabis. "He does hope to abstain from smoking cannabis," Mr Creek added. Chairman of the bench, Jocelyn Abel, said: "We sincerely don't want to see you back in court and hope you stop smoking the cannabis." Calton was ordered to pay £303. https://www.edp24.co.uk/news/crime/teen-caught-with-cannabis-in-scole-1-6372055 Bongme
  15. hi Drug gang snacked on lobster as they ran £1 million cannabis farm Liverpool Echo Investigating officers initially thought they were running a catering business because of the size of orders from wholesale supermarket Costco An elaborate and high-level £1 million cannabis farm network run by a gang of Vietnamese nationals led to them being jailed for a total of 42 years. The men kept their secret headquarters at an address in Stenhills Crescent, Runcorn, but presided over 18 Class B factories in Merseyside, Bolton, Bury, Atherton, Leigh. Between July 2018 and March, earlier this year, detectives in Lancashire tracked down the drug operations, leading to 17 people being charged. Fifteen of them were found guilty. Preston Crown Court heard how more than 2,360 plants were recovered during the investigation, which estimating the street value, would have scooped the gang £1 million. The enquiry began after an abandoned Toyota car was found in the street, leading officers to a ordinary-looking terraced address in Wellfield Road, Blackburn, where 110 plants were discovered. That discovery sparked a much more sophisticated and widespread criminal operation. It was nicknamed Operation Sesame. Last week, Quan Dang, 32, Hung Pham, 29, Tran Hung, 36, and Vo Duc, 20 - were jailed for between 31 and 48 months, for their roles supporting the network. Eleven conspirators have already been sentenced. The ringleaders, Thanh Nguyen, 20, Dung Pham, 28, and Tung Pham, 26, who arranged for complex lighting and heating systems to be installed at the properties, were jailed for between 54 months and six years. Prosecutors said bigwig Pham ran a "rest and relaxation hub" for cannabis growers in Bury and was found to have bought "colossal amounts of beef, lobster and other seafood." Investigating officers initially thought he may be running a catering business because of the size of his orders from wholesale supermarket Costco. Detective Sergeant Stu Peall, of Lancashire Police, said: “I welcome these sentences which reflect the serious nature of the offending. "This was a sophisticated organised criminal group making huge amounts of money from their operation. "We will continue to proactively target the production of cannabis which can have lasting physical and mental health effects on users as well as having a negative effect on our communities and fuelling other crime and we are determined to tackle that. "We need the public to continue to work with us to help us tackle drug crime by informing us of any suspicious activity.” It was heard how some of the cannabis farmers had been working to repay debts to people who had smuggled them into the UK. One barrister said his client was brought into the UK in a refrigerated lorry from Germany. https://www.liverpoolecho.co.uk/news/liverpool-news/runcorn-house-secret-hq-1-17239230 Bongme
  16. hi Cannabis Patient Advocacy and Support Services launched in light of announcement NHE Following the announcement on Monday 11th of November that 1.4 million British adults use street cannabis to treat chronic medical conditions, a new patient advocacy organisation has been launched. The organisation will focus on support and care for patients considering cannabis for medicinal treatment is launching at The Royal College of Nursing. The organisation is titled the Cannabis Patient Advocacy and Support Services and is chaired by Former Health Minister and Fellow of the Royal College of Nursing and Queens Nursing Institute, Ann Keen RN. The initiative will begin by working towards better patient access and care in the regulated medicinal cannabis framework in the UK. CPASS is working with condition charity groups and frontline healthcare providers, to help patients with long term conditions. Medicinal cannabis is being considered by the medical community for conditions such as drug-resistant epilepsy, MS, neuropathic pain and chemotherapy-induced nausea and vomiting, and many leading researchers have shown indications of broader use beyond these conditions. CPASS are calling on clinical nurse specialists (CNS nurses), offering support and training to be able to deliver best care for patients following the new NICE guidelines on cannabis-based medicinal products. Patients considering medicinal cannabis would be able to ask specific questions to their condition and also concerns they may have over how to use CBMPs. CPASS can offer non-judgemental and confidential advice for patients to alleviate concerns over safe consumption and how to use medicinal cannabis. The UK Home Office and Department for Health and Social Care back in 2018 took the decision to legalise and regulate cannabis for medicinal use. The Royal College of Nursing has proactively sought to support these changes. CPASS chair, Ann Keen RN says: “My values as a Registered Nurse are about having justice and equality of care for all patients. As a former community District Nursing Sister, I am aware that today’s Nurses require education and training to inform and support the patient and family with the best knowledge that we have, with the most up to date understanding of cannabis-based medicinal products.” http://www.nationalhealthexecutive.com/Robot-News/cannabis-patient-advocacy-and-support-services-launched-in-light-of-announcement- Bongme
  17. hi Cannabis Patient Advocacy and Support Services launched in light of announcement NHE Following the announcement on Monday 11th of November that 1.4 million British adults use street cannabis to treat chronic medical conditions, a new patient advocacy organisation has been launched. The organisation will focus on support and care for patients considering cannabis for medicinal treatment is launching at The Royal College of Nursing. The organisation is titled the Cannabis Patient Advocacy and Support Services and is chaired by Former Health Minister and Fellow of the Royal College of Nursing and Queens Nursing Institute, Ann Keen RN. The initiative will begin by working towards better patient access and care in the regulated medicinal cannabis framework in the UK. CPASS is working with condition charity groups and frontline healthcare providers, to help patients with long term conditions. Medicinal cannabis is being considered by the medical community for conditions such as drug-resistant epilepsy, MS, neuropathic pain and chemotherapy-induced nausea and vomiting, and many leading researchers have shown indications of broader use beyond these conditions. CPASS are calling on clinical nurse specialists (CNS nurses), offering support and training to be able to deliver best care for patients following the new NICE guidelines on cannabis-based medicinal products. Patients considering medicinal cannabis would be able to ask specific questions to their condition and also concerns they may have over how to use CBMPs. CPASS can offer non-judgemental and confidential advice for patients to alleviate concerns over safe consumption and how to use medicinal cannabis. The UK Home Office and Department for Health and Social Care back in 2018 took the decision to legalise and regulate cannabis for medicinal use. The Royal College of Nursing has proactively sought to support these changes. CPASS chair, Ann Keen RN says: “My values as a Registered Nurse are about having justice and equality of care for all patients. As a former community District Nursing Sister, I am aware that today’s Nurses require education and training to inform and support the patient and family with the best knowledge that we have, with the most up to date understanding of cannabis-based medicinal products.” http://www.nationalhealthexecutive.com/Robot-News/cannabis-patient-advocacy-and-support-services-launched-in-light-of-announcement- Bongme
  18. Hi Man caught growing 700 cannabis plants has hearing to claw back cash adjourned A man found growing around 700 cannabis plants in an outbuilding, near Swaffham, has had his hearing to claw back cash adjourned. Charles Nichols, 67, was sentenced to 24 months jail suspended for two years for production of cannabis and illegally abstracting electricity between January 2017 and February 2018, after police raided his home in Houghton Lane, North Pickenham. Norwich Crown Court heard the raid on February 7, last year, was carried out after a police drone found a large amount of heat coming from a shed. Officers discovered a sophisticated set up with hydroponic equipment and a total of 693 plants together with herbal cannabis and Nichols claimed he was growing the drug for cannabis oil for his personal health reasons Nichols was back in court on Monday for a proceeds of crime hearing but it was adjourned until January 14. https://www.edp24.co.uk/news/crime/charles-nichols-has-confiscation-hearing-adjourned-1-6370042 Vid On Link Bongme
  19. hi Teen caught sneaking cannabis into prison in bid to pay off drug debt Ethan Ings, 18, was caught trying to smuggle a package down his trousers into HMP Parc in Bridgend A teenager got caught with a package containing cannabis and mobile phones when he tried to visit a prisoner at HMP Parc to pay off a drug debt. Ethan Ings, 18, attended the Bridgend prison at around 10.40am on March 8 in order to deliver the package to an inmate. But when he reached the search area he was approached by a security officer who asked Ings to accompany him to a private search room. When he reached the room Ings placed his hand down his trousers and produced a package wrapped in cling film and gave it to the officer. It was later found to contain 27.5g of cannabis, 10 tablets, 17.6 of tobacco, two black Zanco mobile phones, sim cards, and black cables. A sentencing hearing at Cardiff Crown Court heard Ings was interviewed and claimed he thought the package contained tobacco only and he had been paid £300 to bring it into the prison. The defendant, of previous good character, was said to have carried out the act in order to pay off a drug debt after losing his job, which left him unable to fuel his cannabis habit. He pleaded guilty to two counts of conveying a prohibited item into prison. Defence barrister Derrick Gooden said: "The defendant has made a fatal error of judgement. It was ultimately his decision to place those items where they were and he blames himself for getting into that position through his cannabis use and built-up debt. "He was given the opportunity to pay off that debt by taking those items that weren't meant to be in prison into prison. Sentencing, Judge Richard Twomlow said: "It's behaviour like this which causes all sorts of difficulties in a prison, all of which are really quite obvious. "The effects of such offending on the prison regime and the difficulty it presents means deterrent sentences need to be passed." Ings, of Aberporth Road, Gabalfa , Cardiff , was sentenced to 14 months detention in a young offenders' institute. https://www.walesonline.co.uk/news/wales-news/ethan-ings-gabalfa-cardiff-court-17236770 Bongme
  20. hi NICE publishes guidance on cannabis-based medicinal products The National Institute for Health and Care Excellence has published guidance on cannabis-based medicinal products. The guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy. Cannabis-based products for medicinal use as set out by the UK Government in the 2018 Regulations The licensed products delta-9-tetrahydrocannibinol combined with cannabidiol (Sativex) and nabilone Plant-derived cannabinoids such as pure cannabidiol (CBD) Synthetic compounds which are identical in structure to naturally occurring cannabinoids such as delta-9-tetrahydrocannabinol (THC), for example, dronabinol. It approves Epidyolex on the NHS for Lennox-Gastaut and Dravet syndromes which are rare forms of epilepsy. Sativex has been recommended on the NHS for multiple sclerosis. Sarah Ellson, a regulatory lawyer specialising in healthcare at Fieldfisher responded to the news saying: “Today’s news is welcomed by many, but there is still disappointment surrounding the restrictions on prescribing cannabis-based drugs in the UK. “Although frustration with the UK’s (and EU’s) current regulatory position on cannabis continues to mount, more information is becoming available and regulators are slowly manoeuvring into a position to make informed decisions. “As things stand, industry consensus appears to be that restrictions on medical and medicinal cannabis use will ease as more companies progress through the relevant approvals processes.” Sapphire Medical Clinics welcomed the NICE decision to make Sativex available on the NHS in particular circumstances for certain MS patients. However, they expressed concern that the guidelines do not allow for more general access to medical cannabis for other conditions. They suggest that the guidelines show that the NICE methodology and approach to the developing area of cannabis-based medicinal products may need to be refined. Dr Mikael Sodergren, Managing Director of Sapphire Clinics and academic lead explains: “NICE justifiably enjoys a very high reputation both nationally and internationally for its world leading work. It rightly puts the highest emphasis on evidence from Random Control Trials (RCTs). However, the evidence from such RCT trials is some years away as they are complex, lengthy and take considerable time to undertake. Usually, RCTs precede the availability of medicines. But we are in the ‘real world’ situation of cannabis-based medicinal products being available and in use elsewhere before the RCT evidence base has been developed. “So in the short to medium term we believe NICE should consider refining its approach and take a broader view of what evidence to consider when making its recommendations. Additionally, we believe it should take a more holistic view of how it judges cost effectiveness.” https://pharmafield.co.uk/healthcare/nice-publishes-guidance-on-cannabis-based-medicinal-products/ Bongme
  21. hi Pair arrested for suspected cannabis factory burglary Two men have been arrested after allegedly breaking into a suspected cannabis factory The pair, 22 and 24 years old, were arrested at 1.30am this morning (Tuesday, November 12) following a foot chase from a suspected cannabis factory they had allegedly broken. Police officers also arrested a 32-year-old woman at the address in Waltham Forest on suspicion of cultivating cannabis. All three remain in police custody. The East London Guardian will update readers with more details as they are released. For more breaking news, local headlines, What’s On features and sport, follow our Facebook pages: facebook.com/EastLondonGuardian and facebook.com/EppingForestGuardian We also have Twitter accounts: @ELondonGuardian and @EppingFGuardian 'Like’ and follow us to keep up-to-date with news in east London and west Essex. https://www.guardian-series.co.uk/news/18030694.pair-arrested-suspected-cannabis-factory-burglary/ Bongme
  22. hi Harwich man to appear in court for rape and cannabis charges A man is due to appear in court today to face charges of rape and possession of cannabis. Daniel Stott, 26, of Coke Street, Harwich will appear at Colchester Magistrates Court. Essex Police are investigating the rape of a woman reported to have happened on Saturday November 9 in Boxted Avenue, Clacton. If you have any information about the incident, CCTV or mobile footage of the area around this time that might be of help, please call Essex Police on 101 quoting crime reference 42/178662/19. https://www.harwichandmanningtreestandard.co.uk/news/north_essex_news/18030438.harwich-man-appear-court-rape-cannabis-charges/ Bongme
  23. hi CBD oil: benefits, uses and the best available in the UK CBD oil has become a huge wellness trend in 2019. The medicinal product, which you can buy in a number of shops in the UK, has rapidly increased in demand over the last few years. According to the BBC, there are now an estimated quarter of a million regular users in the UK alone. The benefits of cannabis-based medicines also continue to be introduced by the NHS, with two cannabis drugs for epilepsy and multiple sclerosis being ‘approved’ for the first time in November 2019. However, no prescription is required. Holland & Barrett became the first high street store to stock medical cannabis oil in the UK in February 2018. It is now a common product in both Superdrug and Boots, as well as a number of other UK retailers, too. What is CBD oil? There are two main compounds in cannabis: CBD (cannabidiol) and THC (tetrahydrocannabinol). It is the THC that is the psychoactive constituent and illegal in the UK. CBD oil, however, is legal as it is made from a natural ingredient found in hemp plant. “CBD is a chemical substance found in cannabis that has medical benefits. It won't get you high, because it doesn't contain THC (tetrahydrocannabinol), the chemical in cannabis that makes you high” explains the NHS website. The Home Office only allows licences for oils in the UK that are cultivated from plants with approved seed types and contain a THC content of 0.2% or less. How does CBD oil help? Research is still being administered by multiple organisations in the UK to prove the health benefits of CBD oil. It is, however, mostly praised by users for helping insomnia, anxiety, chronic pain and period pain. How to choose a CBD oil Currently CBD oil is not clearly regulated, but, The World Health Organization states “CBD is generally well tolerated with a good safety profile”. When searching for CBD oil it’s important to check it’s free from pesticides and solvents, it includes no more than 0.2% THC and that it’s from a trusted brand. There are also varying strengths of CBD oil, the lowest being 300mg (3%) ranging to 800mg (8%). It’s suggested you start at a low dosage and gradually build up your tolerance. We tried it: Shop the best CBD oils on the high street Yahoo is committed to finding you the best products at the best prices. We may receive a share from purchases made via links on this page. After finishing around four CBD oils over the past year, I was ecstatic when I stumbled upon Green Stem, who has created flavoured CBD oils that don’t share the usual unpleasant earthy taste. I tried the Seville orange, but there are also black cherry and peppermint flavours available. The broad-spectrum hemp blend is THC free and has been lab tested for purity. I would most definitely join customers who have already given it an overall 4.9 out of 5 rating. Made from EU-certified hemp crops in Cooley Mountains of Ireland and produced without fungicides, pesticides or herbicides, Celtic Wind is a worthy first-time choice if you’re wanting to try a CBD oil. It’s advised you take one pipette (0.7ml), once a day, under your tongue. Other brands often allow more drops a day, so I found one drop wasn’t enough for the effects to last the entire day. However, for a CBD newbie who doesn’t want to take it numerous times a day it’s probably ideal. It also wasn’t the most pleasant tasting CBD oil (spoiler alter: CBD oil does not taste good in general, but usually the pay off is worth it). Stocked at Boots, Dragonfly CBD is on the more expensive end of the spectrum. That’s because it’s extracted from organically grown Cannabis Sativa plants using a hand-crafted extraction method. The brand are also very transparent with its production, proving organic certification, batch numbers and pesticide testing. With 5.6% CBD, it’s higher strength. Taste wise, I found it a little less oily than others. I was lured in by the promise of an “easy-to-use peppermint flavoured oral drops” - and I was not disappointed. The hint of peppermint was refreshing, making it another great option for those who don’t like the usual CBD taste. The oil also held a clear consistency, showing the brands filter-clear method, which removes unwanted plant. Endoca is a brand that I’ve been suggested by multiple avid CBD users. It contains only full spectrum hemp oil and CBD. If you can’t stomach the not-so-pleasant tasting oils, these capsules are the solution. The only down side is that you’re confined to a fixed dosage rather than measuring it yourself using drops. However, not having to taste the oil made it so, so worth it. CBD Oil Drops Seville Orange (5%) by Green Stem | £45 Crops Oil (5%) by Celtic Wind | £29.99 Cannabidiol Oil (5.6%) by Dragonfly CBD | £40 Super Strength CBD Oil Drops (5%) by Health Span | £28.95 Raw CBD Capsules by Endoca (10mg per capsule) | from £23 https://news.yahoo.com/best-cbd-oil-in-the-uk-095902968.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAAt418jOAMoCKbfSBqwNBseRXwhfyNy1m-IzBE6mfU3jm7e8VMMJVeKUYu0zfOAN06qFVTSbWszRsdI4jaREHlhiZrt0WvOrr-IQZ7PuVdXZr6ixUnuP_OZ2TJIfco0dTVTxzEwEONuHM5HBpOJyCaOSGFWtwHjzjlqLeudH10uy Photos on Link Bongme
  24. hi Police in Ashford find cannabis in a bag left at a bank Officers got more than they bargained for when a lost bag was reported to them. Police attended a bank in Ashford to collect a forgotten rucksack. However, when they looked inside the orange camouflage-print carrier they discovered a bag of marijuana. The town team unit tweeted: "Would the owner please contact us quoting reference 11-0897 so we can return it to you, minus the cannabis." https://www.kentonline.co.uk/ashford/news/officers-find-drugs-in-lost-bag-216066/ Bongme
  25. Hi Cannabis plants totaling 166 seized by police in Bradford centre A man found growing around 700 cannabis plants in an outbuilding, near POLICE have seized 166 cannabis plants from a street just behind a city centre business park. Officers discovered the plants on Saturday afternoon, in St Andrew's Villas, which is just behind the Fieldhead Business Centre. PCSO Andrew Gelder said: "Was only a matter of time before we sniffed this one out." The plants will now be destroyed. https://www.thetelegraphandargus.co.uk/news/18030127.cannabis-plants-totaling-166-seized-police-bradford-centre/ Bongme